2003

More products for inpatient and outpatient treatment were released. The Tchaikapharma brand became synonymous with quality and affordability in the eyes of doctors and patients.

New products

Atenolol-Tchaikapharma (atenolol), Ceftriaxon-Tchaikapharma (ceftriaxon), Diclofenac-Tchaikapharma (diclofenac), Spironolacton-Tchaikapharma (spironolacton).

Expansion of manufacturing facilities
A second labeling installation for vials was put in operation after a contract with F. Hoffmann-La Roche was executed for the manufacturing of Madopar tablets 250 mg (levodopa/carbidopa).